-
Most Recent
Search Results
240 results for CEL
When the Smartest People Start Leaving, This Might Be Why
In today’s Friday Digest takeover, Stansberry Research analyst Josh Baylin explains why one of the most powerful indicators in today’s market isn’t found in financial…
AI’s Real “Demon” Has Nothing to Do With Robots
Musk’s warning revisited… the Prisoner’s Dilemma hiding everywhere you look … why the usual reassurances don’t apply this time… and where the smart money actually…
What You’re Not Being Told About the AI Economy
A massive AI wealth transfer may already be underway as tech companies enclose the infrastructure of the AI economy.
What the PCE Is Really Telling Investors Today
The ceasefire is fragile – but appears to be holding… this morning’s PCE confirms inflation is creeping higher… and what investors should be thinking about…
Copper Demand Isn’t Slowing – It’s Accelerating
The short-term story for copper is simple; demand is growing faster than expected, supply is growing slower than expected, and the market is already slipping…
AI Layoffs Are Spreading Faster Than Expected
AI layoffs are accelerating across tech, fintech, and banking. This is a structural shift – not a temporary trend.
#CELShortSqueeze Campaign Sends CEL Crypto Prices Soaring
The #CELShortSqueeze hashtag is mobilizing investors to buy up massive amounts of the CEL crypto as a way to trigger price run-ups.
Trump’s Iran Update Spikes Volatility. Now What?
Stocks gyrate after Trump extends the Iran timeline… what yesterday’s jobs data tells us… AI agents are coming for jobs… how to invest ahead of…
The Market Has Already Changed … but Most Investors Haven’t
When Amazon went public, those who understood what was coming and moved early built a fortune. Everyone who waited for confirmation might still have made…
CVM Stock Earnings: CEL-SCI Reported Results for Q4 2023
CEL-SCI just reported results for the fourth quarter of 2023.
CVM Stock Earnings: CEL-SCI Reported Results for Q2 2024
CEL-SCI just reported results for the second quarter of 2024.
Celsius Price Predictions: Where Will the CEL Crypto Go After Major Crash?
Celsius (CEL) price predictions are on the mind of traders today as they deal with a crypto crash that pulling the market down.
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.
CVM Stock: Why Cancer Play Cel-Sci Is Riding the Reddit Wave
CVM stock is on the move after Cel-Sci CEO Geert Kersten joined the battle against GME stock short-sellers. Here’s what to know.
CVM Stock Earnings: CEL-SCI Misses EPS for Q3 2024
CVM stock results show that CEL-SCI missed analyst estimates for earnings per share the third quarter of 2024.
Celsius Network Looks to Return Customer Funds, Reversing CEL Crypto Losses
The Celsius Network is seeing CEL crypto prices fly upward in response to its motion in court to return $50 million in user funds.
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.
CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
CRSP stock is rallying after an FDA panel appeared to view CRISPR Therapeutics’ sickle-cell anemia treatment as safe.
Go Long CEL, Short DTV
Cellcom Israel Ltd. (NYSE: CEL) is ready for another leg up, while DIRECTV (NASDAQ: DTV) is encountering overhead resistance.
Why Is Crispr Therapeutics (CRSP) Stock Up Today?
Crispr Therapeutics (CRSP) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review.
What Anthropic’s Latest Model Signals for Investors
In today’s Smart Money, let’s examine the latest AI developments that are leading the push toward AGI. Then, I’ll share my three-part investment strategy you…
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.
CVM Stock: The Big Trial News That Has Cel-Sci Plunging Today
Today, the trial results reported by Cel-Sci missed the mark, and investors are pricing in additional risks with CVM stock.
4 – 10 of 240 results
